mglur2

3-MATIDA 是一种有效的 mGluR-1 拮抗剂（IC50：6.3 μM，大鼠 mGluR-1a）。显示出 ≥ 40 倍于其他受体的选择性：mGluR-5、mGluR-2、mGluR-4 (mGluR-4a) (IC50 > 300 μM)、NMDA 和 GluR (AMPA) (IC50 = 250 μM)。 3-MATIDA 在体外培养的鼠皮质细胞和大鼠海马切片培养物中充当神经保护剂。

EGLU ((2S)-α-Ethylglutamic acid) 是一种竞争性 mGluR-2 受体拮抗剂，具有抗抑郁活性和抗伤害作用，可用于研究关节炎。

LY-2300559 是代谢型谷氨酸受体 2 (mGluR2) 的激动剂，可用于偏头痛治疗的研究。

LY404039 (pomaglumetad) 是可口服的mGluR2和mGluR3选择性激动剂，有抗精神病和抗焦虑的作用。它对重组人mGluR2和mGluR3的Ki 分别为 149 和 92 nM，比对其他受体 转运蛋白的抑制性高 100 倍以上。

Decoglurant (RO4995819) 是 mGluR2和 mGluR3的负变构调制器，有抗抑郁作用。

LY2979165 (mGlu2 agonist) 是 mGluR2 的正构激动剂，可用于作为抗抑郁药的研究。

L-Cysteinesulfinic acid monohydrate 是代谢型谷氨酸受体 (mGluRs) 的有效激动剂，可以作用于 mGluR1，mGluR2，mGluR5，mGluR4，mGluR6 和 mGluR8，pEC50分别为 3.92，3.9，4.6，2.7，4.0，和 3.94。

AZD-8529 mesylate 是高度选择性的可口服mGluR2正向调节剂，EC50值为 285 nM。它在 20-25 M 时，对 mGluR1、3、4、5、6、7 和 8 亚型没有显示正变构调节剂反应。

Oxomemazine 是毒菌碱 M1 受体的选择性拮抗剂，具有明显的抗毒蕈碱活性。它是基于吩噻嗪的组胺 H1 受体阻滞剂，是抗组胺和抗胆碱能试剂，可用于咳嗽相关研究。

VU-29 是代谢型谷氨酸 5(mGlu5)受体的正变构调节剂，对 rmGluR5 的 EC50为 9 nM，Ki 为 244 nM。相对于其他亚型，它对 mGluR5 具有选择性，对 rmGluR1 rmGluR2和 hmGluR4的 EC50分别为557 nM 1.5 μM 和 154 nM。

trans-ACPD ((±)-trans-ACPD) 是代谢型受体激动剂，可促进钙离子活动及产生内向电流。

LY341495 是高效的代谢型谷氨酸受体拮抗剂，对多种谷氨酸受体的亚型表现除很高的活性，可用于研究神经系统疾病。

(RS)-MCPG ((±)-MCPG) 是一种竞争性和选择性 I II 组代谢型谷氨酸受体 (mGluR) 拮抗剂，可阻断 TBS 诱导的幼年和新生大鼠海马神经元的转变。

PHCCC ((-) PHCCC) 是 I 组代谢型谷氨酸受体拮抗剂和 mGluR4 的正变构调节剂。 它对 mGluR2 和 mGluR8 也有很强的拮抗作用，具有抗帕金森病作用。

mGluR2 modulator 2 (compound 2) 可用于抗精神病药物研究。mGluR2 modulator 2 是一种有效的、选择性和口服生物可利用的mGluR2正变构调节剂，EC50值为 0.13 μM。

mGluR2 antagonist 1 is a potent and selective class of negative allosteric modulator targeting the metabotropic glutamate receptor 2 (mGluR2) with high oral bioavailability. It displays a remarkable affinity for mGluR2, with an IC50 value of 9 nM. Furthermore, it exhibits excellent permeability across the blood-brain barrier, making it a promising candidate for central nervous system-related studies or therapies.

mGluR2 modulator 4 (compound 47) is a highly potent positive allosteric modulator of mGluR2, exhibiting an EC 50 value of 0.8 μM. It holds the potential for investigating antipsychotic properties [1].

mGluR2 modulator 1 (compound 95) 是一种有效的、具有血脑屏障通透性的 mGluR2 (代谢型谷氨酸受体-2)正向变构调节剂 (EC50: 0.03 μM)。mGluR2 modulator 1 能够用于研究精神病。

mG2N001 是代谢型谷氨酸受体 mGluR2 的负变构调节剂 (NAM) (IC50: 93 nM)，并作为拮抗剂与 mGluR2 结合 (Ki: 63 nM)。mG2N001 具有微粒稳定性和血浆稳定性，其放射性同位素 [11C]mG2N001 可用于 PET 成像。[11C]mG2N001 的脑异质性和脑渗透性好，能够选择性地积累在富含 mGluR2 的区域，产生高对比度的大脑图像。

LY3020371 hydrochloride exerts an antidepressant-like signature in vivo. LY3020371 hydrochloride is a potent, selective metabotropic glutamate 2/3 receptor (mGlu2/3) antagonist with Ki of 5.3 and 2.5 nM, potently blocks cAMP formation with IC50 of 16.2 nM.

LY2794193 is a highly effective and selective agonist of the mGlu3 receptor (hmGlu3 Ki=0.927 nM,EC50=0.47 nM; hmGlu2 Ki=412 nM,EC50=47.5 nM).

MGS-0039 is a group II metabotropic glutamate receptor (mgluR2/3) antagonist. Antidepressant-like action of group II mGlu receptor antagonists does not depend on serotonergic system activation. However, the AMPA receptor seems to play a key role in the an

group I mGlu1a/1a receptor antagonist and mGluR2 agonist

LY487379是一种选择性的人类 mGluR2 阳性异生调节剂（PAM）。LY487379 可提高谷氨酸刺激的 [35 S] GTPγS 结合，作用于 mGlu2 受体 (EC50: 1.7 μM) 和 mGlu3 受体 (EC50>10 μM)。LY487379 在大鼠模型中促使认知的灵活性，并诱导行为抑制。LY487379 能够用于研究精神分裂症。

LY2812223 is a highly effective and functionally selective mGlu2 receptor agonist. It has a mGlu2 binding affinity for mGlu2 and mGlu3 (Ki=144 nM and 156 nM, respectively).

GSK1331258 is a selective, orally bioavailable positive modulators of mGluR2.

Biphenylindanone A is a selective potentiator of human mGluR2 (hmGluR2),and for the treatment of neurological disorders.

LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from human ionotropic and metabotropic glutamate (mGlu) receptors expressed in non-neuronal cells.

AZD-8529 is a highly selective, and orally bioavailable positive allosteric modulator of mGluR2 (EC50: 285 nM). It shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.

LY3020371 is a highly potent and selective antagonist targeting the glutamate (mGlu) 2/3 receptor, showcasing excellent inhibition at Ki values of 5.26 nM and 2.50 nM for hmGluR2 and hmGluR3, respectively. With its remarkable affinity and specificity, LY3020371 serves as a valuable tool in depression research.

MK-8768为口服生效且能穿越血脑屏障的选择性mGluR2负向变构调节剂，其IC50为9 nM。

JNJ-46281222 is an metabotropic glutamate (mGlu) 2-selective, highly potent PAM (positive allosteric modulator). It has nanomolar affinity (Kd = 1.7 nM) and a high modulatory potency (pEC50 = 7.71).

GSK1331268 is a selective, orally bioavailable positive modulators of mGluR2.

L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors [mGluRs, pEC50s of 3.92±0.03, 4.6±0.2, 3.9±0.2, 2.7±0.2, 4.0±0.2, and 3.94±0.08 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively].

LY307452 is a selective antagonist of mGluR2 3.

Ro4491533 is a potent and selective negative allosteric modulator for group II of the metabotropic glutamate receptors (mGluR2 3).

Talaglumetad (hydrochloride) 是Eglumegad 的前药，Eglumegad 是II 型代谢型谷氨酸受体(mGluR2 3)有效选择性的激动剂，用于治疗焦虑等精神疾病。

AZ12559322，作为mGluR2的正向变构调节剂，其Ki值达1.31 nM。该化合物主要应用于神经系统相关的科学研究。